ECO MEDICS offers an innovative range of computerized pulmonary diagnostic products ranging from infants (>3 kg), children to adults for routine clinical and scientific research. The innovative design of ECO MEDICS products and their continuous improvement are supported by cooperation with leading scientists from around the world in order to meet the needs of the international community of pulmonologists.
CVS Specialty
CVS Specialty® is the largest specialty pharmacy in the U.S., serving patients with complex and chronic conditions. Patients are supported by dedicated care teams of pharmacists, nurses, and skilled clinicians who specialize in specific conditions. We prioritize communication with healthcare providers to streamline the prescribing process and focus on personalized patient communication and support, to help ensure that patients successfully begin and continue their therapy.
coVita
For 45+ years, coVita has been providing breath analysis devices for medical applications, research and to improve public health. coVita’s main focus is to bring to market simple to use, accurate, non-invasive diagnostic tools with innovative features. Our latest FDA cleared product, the NObreath® FeNO monitor aids in asthma management, shows patient adherence to treatment, aids in identifying patients who do/do not require on-going treatment, and in differentiating between allergic (eosinophilic) and non-allergic (non-eosinophilic) asthma.
CHILDREN’S HEALTH
Children’s Health℠ is the leading pediatric healthcare system in North Texas and has long been recognized as a leader in pediatric health. Children’s Health campuses include Children’s Medical Center Dallas, Children’s Medical Center Plano, and multiple Children’s Health Specialty Centers. With its academic partner, UT Southwestern, Children’s Medical Center Dallas is consistently ranked #1 children’s hospital in North Texas and among the nation’s best pediatric hospitals by U.S. News & World Report. Its commitment to excellence and providing outstanding care across all aspects of pediatrics has resulted in 11 out of 11 specialty programs being ranked among the best for six consecutive years, including Cancer, Cardiology & Heart Surgery, Diabetes & Endocrinology, Gastroenterology & GI Surgery, Neonatology, Nephrology, Neurology & Neurosurgery, Orthopedics, Pulmonology, Urology, and Behavioral Health.
Chiesi USA
Chiesi is a global biopharmaceutical company that develops and markets innovative therapeutic solutions in respiratory health, rare diseases and specialty care. Through its US affiliate headquartered in Cary, NC, the company is bringing a fresh perspective to the US respiratory landscape that is informed by 90 years of global pharmaceutical leadership. As a privately-owned, values-driven pharmaceutical company that is committed to generating economic value in a way that benefits society, Chiesi seeks to create lasting, shared value for people, patients, the planet, and our business.
Canadian Thoracic Society
The Canadian Thoracic Society (CTS) is Canada’s national inter-professional specialty society for respirology bringing together over 1,000 members representing specialists, physicians, researchers and healthcare professionals from a variety of disciplines working in respiratory health. For more information on CTS, please visit our website at www.cts-sct.ca
Boehringer Ingelheim Pharmaceuticals
We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches. We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research. Simply put, for Boehringer Ingelheim, cancer care is personal, today and for generations. Read more here: https://www.boehringer-ingelheim.com/human-health/cancer | Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.us | At Boehringer Ingelheim we are driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our FOCUS articulates who we are and what we strive for, why we exist, how we work and what we want to achieve.